
Planned and actual healthcare and life sciences activity in 2020, by subsector
In 2020, according to the surveyed U.S. investment professionals, 35 percent reported that the biopharma industry even increased its deal activity compared to plans at the beginning of the year. This statistic illustrates the actual healthcare and life sciences deal activity in 2020 compared to plans at the beginning of the year, by subsector.